Loading...
News and Publications2020-04-22T17:56:03-04:00

News

Keep up with Ology Bioservices. Here’s our latest…

News

U.S. ARMY CONTRACTING COMMAND AWARDS OLOGY BIOSERVICES CONTRACT TO RESERVE PRODUCTION CAPACITY IN SUPPORT OF OPERATION WARP SPEED

August 26th, 2020|

Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract by the U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland. The contract ceiling value is $106.3 million, of which $53.1 million was obligated at the time of award.

Ology Bioservices Wins Three Department of Defense Awards Totaling More Than $16 Million

July 8th, 2020|

ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of more than $16 million.

Department of Defense Awards Ology Bioservices Contract to Advance Anti-Botulism Neurotoxin Monoclonal Antibodies

June 25th, 2020|

ALACHUA, Fla. – June 25, 2020 – Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract to advance development of a cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD) through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The contract ceiling value is $42.6 million.

Just – Evotec Biologics to Collaborate with Ology Bioservices on Antibodies Against Coronavirus

April 30th, 2020|

Ology and Just - Evotech Collaborate to Develop Antibodies Against Coronavirus Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention of infection with Sars-CoV-2 Just – Evotec Biologics to supply antibody screening and analytical characterization of anti-covid-19 antibodies

View news from 2015 or earlier here

Publications

2020

Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopyBioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137

Read More >

2019

2018

2017

2016

Go to Top